Neumann A U, Lam N P, Dahari H, Davidian M, Wiley T E, Mika B P, Perelson A S, Layden T J
Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel.
J Infect Dis. 2000 Jul;182(1):28-35. doi: 10.1086/315661. Epub 2000 Jul 6.
Many studies have shown that patients infected with hepatitis C virus (HCV) of genotype 2 have better response to interferon (IFN)-alpha treatment than genotype 1 patients; however, the mechanisms responsible for this difference are not understood. In this study, viral dynamics during high-dose IFN induction treatment were compared between the genotypes. Patients in each group received 10 MU of IFN-alpha2b for 14 days, and HCV RNA levels were frequently determined. Nonlinear fitting, both individually for each patient and using a mixed-effects approach, of the viral kinetic data to a mathematical model of the IFN effect on HCV infection was performed. The antiviral effectiveness of IFN in blocking virus production, the free virion clearance rate, and the HCV-infected cell death rate were all significantly higher for genotype 2 patients than for genotype 1 patients. Thus, the better response rate of patients infected with HCV genotype 2 is multifactorial. This is the first finding of a difference in viral dynamics between subtypes of the same virus and demonstrates the importance of subtype-specific virus-host-drug interactions.
许多研究表明,丙型肝炎病毒(HCV)2型感染者对干扰素(IFN)-α治疗的反应比1型感染者更好;然而,造成这种差异的机制尚不清楚。在本研究中,对不同基因型在高剂量IFN诱导治疗期间的病毒动力学进行了比较。每组患者接受10 MU的IFN-α2b治疗14天,并频繁测定HCV RNA水平。对病毒动力学数据进行非线性拟合,分别针对每位患者并采用混合效应方法,使其符合IFN对HCV感染影响的数学模型。2型患者中IFN在阻断病毒产生方面的抗病毒效力、游离病毒粒子清除率以及HCV感染细胞死亡率均显著高于1型患者。因此,HCV 2型感染者更好的反应率是多因素的。这是首次发现同一病毒不同亚型之间病毒动力学存在差异,并证明了亚型特异性病毒-宿主-药物相互作用的重要性。